UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037027
Receipt number R000042181
Scientific Title prostate biopsy based on transrectal ultrasound and MRI fusion imaging
Date of disclosure of the study information 2019/07/01
Last modified on 2019/12/04 21:32:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination about the usefulness in cancer localization diagnosis of prostate biopsy using BioJet system

Acronym

Biojet prostate biopsy

Scientific Title

prostate biopsy based on transrectal ultrasound and MRI fusion imaging

Scientific Title:Acronym

MRI-US fusion prostate biopsy

Region

Japan


Condition

Condition

prostate cancer

Classification by specialty

Urology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to investigate whether prostate biopsy performed using the BioJet system can improve diagnostic rates and accurate prostate cancer localization.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Biopsy positive rate

Key secondary outcomes

safety such as bleeding, infection after biopsy


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Prostate biopsy using biojet system

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >

Gender

Male

Key inclusion criteria

Target patients who meet all the following criteria
1) Patients with serum PSA level between 2.5 ng / ml and 50 ng / ml
2) PIRADS score 3 or more on MRI before biopsy
3) Patients 20 years of age or older at the time of consent acquisition
4) Patients who obtained written consent by the patient's own free will after sufficient understanding after participating in this study

Key exclusion criteria

I. A patient who is judged not to contribute to a patient's life prognosis by a definite diagnosis of prostate cancer
II. Patients suspected of developing prostate cancer with serum PSA> 50 ng / ml
III. Patients suspected of having advanced prostate cancer by rectal examination
IV. Patients suspected of having advanced prostate cancer by MRI
V. Patients who can not have prostate biopsy due to blood coagulation abnormality
VI. Patients who can not be under spinal anesthesia, sacral anesthesia or general anesthesia because they have allergies to anesthetic agents
VII. Other patients who were judged inappropriate by the doctor in charge of this study

Target sample size

5


Research contact person

Name of lead principal investigator

1st name ATSUSHI
Middle name
Last name TAKAMOATO

Organization

Okayama University Hospital

Division name

Department of Urology

Zip code

7008558

Address

kita-ku, shikata-tyo, 2-5-1

TEL

0862357287

Email

p1v91oga@okayama-u.ac.jp


Public contact

Name of contact person

1st name takamoto
Middle name
Last name atsushi

Organization

Okayama University Hospital

Division name

Department of urology

Zip code

7008558

Address

kita-ku, shikata-tyo, 2-5-1

TEL

0862357287

Homepage URL


Email

p1v91oga@okayama-u.ac.jp


Sponsor or person

Institute

Okayama University Hospital

Institute

Department

Personal name



Funding Source

Organization

Okayama University Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Okayama University Hospital Department of urology

Address

kita-ku, shikata-tyo, 2-5-1

Tel

0862357287

Email

p1v91oga@okayama-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 06 Month 03 Day

Date of IRB

2019 Year 06 Month 25 Day

Anticipated trial start date

2019 Year 07 Month 01 Day

Last follow-up date

2019 Year 08 Month 31 Day

Date of closure to data entry

2019 Year 08 Month 31 Day

Date trial data considered complete

2019 Year 08 Month 31 Day

Date analysis concluded

2019 Year 09 Month 30 Day


Other

Other related information



Management information

Registered date

2019 Year 06 Month 11 Day

Last modified on

2019 Year 12 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042181


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name